IOL Chemicals And Pharmaceuticals Ltd.
Fundamentals
- Market cap
- ₹3,922 cr
- P/E
- 28.49×
- ROE
- 5.99%
- Debt / equity
- 0.07
- Div yield
- 0.76%
- 52-week range
- 67.14 — 139.85
Company snapshot
IOL Chemicals And Pharmaceuticals Ltd.
Pharmaceuticals
₹3,922 cr
P/E 28.49×
Latest quarter · Mar 2026
Sales₹619 cr
Net profit₹53 cr
Op. margin+14.9%
EPS₹1.81
Strength & growth
Debt / equity0.07×
Current ratio1.85×
Sales CAGR+14.5%
EPS CAGR+44.6%
The timeline — 4 notes on IOL Chemicals And Pharmaceuticals Ltd.
May 2026
- 22 May 26 · 4:31 PM IST Brief Brief · Small cap
IOL paracetamol plant running at 55%, below its own target
Management reaffirmed FY27 growth targets but disclosed a key capacity-utilization miss on its expanded paracetamol line. The stock trades at a discount to its own execution promises.
- 21 May 26 · 12:53 PM IST Brief Brief · Earnings · Small cap
IOL Chem's Q4 & FY26 results: Old news, no surprises
Audited numbers and Triacetin/Pantoprazole expansions were already disclosed. Market knew the story.
- 20 May 26 · 6:39 PM IST Brief Brief · Earnings · Small cap
IOL Chemicals hits record Q4 revenue of ₹619.5 cr, PAT up 68%
Strong momentum in Pharma and Chemicals drives best-ever quarterly performance; ₹164 cr capex announced.